<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[viagra Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/viagra.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to viagra]]></description>
	<s:counts start="0" returned="20" found="92" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Viagra Now Available Intravenously]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005465/viagra-now-available-intravenously/]]></link>
		<description><![CDATA[Well, not quite. The FDA appoved Pfizer PFE's pulmonary arterial hypertension drug Revatio as an injection in cases where the patient is unable to swallow the tablets. Of course, Revatio sildenafil is the same drug as Viagra. It just has a different name and a different set of indications and...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 23 Nov 2009 06:46:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/tablets.html"><![CDATA[Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks.html"><![CDATA[Notebooks]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/hardware.html"><![CDATA[Hardware]]></category>
		<category domain="http://resources.bnet.com/topic/notebooks+%2526+tablets.html"><![CDATA[Notebooks & Tablets]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[As Boehringer Develops Viagra for Women, History Suggests High Risk of Failure]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005293/as-boehringer-develops-viagra-for-women-history-suggests-high-risk-of-failure/]]></link>
		<description><![CDATA[Boehringer Ingelheim is developing a female version of Viagra -- and wading into an infamous graveyard of failed pharma products. Like cures for obesity, therapies to boost flagging libido in women are better known for their failures than their successes. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 13 Nov 2009 08:43:41 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[Women]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/boehringer+ingelheim.html"><![CDATA[Boehringer Ingelheim]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[The 10 Weirdest Drug Stories of the Month]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005078/the-10-weirdest-drug-stories-of-the-month-14/]]></link>
		<description><![CDATA[Spiders make Viagra! A vaccine for cocaine! Canola genes unlocked! It all happened in October ...    	Contraceptive pills change mating choices of women who use them  "One prediction is that offspring of pill users are more homozygous than expected, possibly related to impaired immune function and...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 02 Nov 2009 10:29:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[Researcher]]></category>
		<category domain="http://resources.bnet.com/topic/vaccine.html"><![CDATA[Vaccine]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/bonkers+michigan+law.html"><![CDATA[Bonkers Michigan Law]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pfizer's Viagra Shows Signs of Flagging: Sales Down 6%]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004956/pfizers-viagra-shows-signs-of-flagging-sales-down-6/]]></link>
		<description><![CDATA[Pfizer's Viagra recorded a 6 percent sales decline, to $466 million worldwide. It wasn't just foreign currency headwinds: The decline was 14 percent in international sales and 1 percent in the U.S. Until now, Viagra has been an almost unstoppable growth machine for Pfizer. The company regularly put the price...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 22 Oct 2009 14:03:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[UPDATED: What Agencies Need to Know About Pfizer's Viagra Account]]></title>
		<link><![CDATA[http://industry.bnet.com/advertising/10004221/what-agencies-need-to-know-before-pitching-pfizers-viagra-account/]]></link>
		<description><![CDATA[Any agency pitching Pfizer's Viagra account may want to bear the following in mind: The patent on Viagra expires somewhere between June 2011 and March 2012, which is when the client will likely end its ad budget for the brand. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 06 Oct 2009 06:39:47 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agency.html"><![CDATA[Agency]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/advertising+%2526+promotion.html"><![CDATA[Advertising & Promotion]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Price of Viagra Has Risen 108% Since Launch; 100 Pills Now Cost $1,400]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004198/price-of-viagra-has-risen-98-since-launch-100-pills-now-cost-1400/]]></link>
		<description><![CDATA[The price of Pfizer's Viagra has doubledsince it was launched, according to a list of wholesale acquisition costs paid by pharmacies, obtained by BNET. In May 1999, a 100-count bottle of the blue diamonds cost $700. Today, that same bottle costs $1,457.61, a 108 percent increase, according to the list....]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 10 Sep 2009 15:19:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/bottle.html"><![CDATA[Bottle]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/mergers+%2526+acquisitions.html"><![CDATA[Mergers & Acquisitions]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pfizer Rep Claims Zoloft Touted for Failed Cheerleaders; Viagra for Women]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004174/pfizer-rep-claims-zoloft-touted-for-failed-cheerleaders-viagra-for-women/]]></link>
		<description><![CDATA[Former Pfizer sales rep Blair Collins' whistleblower lawsuit contains a detailed guide to how some of Pfizer's reps allegedly promoted their drugs. Among the tactics they allegedly used were recommending the antidepressant Zoloft for girls who failed to make the cheerleading squad; and staging talks in which doctors recommended prescribing...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 09 Sep 2009 12:22:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[Women]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer Rep Alleges Viagra Promoted With Unapproved Materials: "Get Those Things Cleaned Up!"]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004131/pfizer-rep-alleges-viagra-promoted-with-unapproved-materials-get-those-things-cleaned-up/]]></link>
		<description><![CDATA[Blair Collins, a former Pfizer sales rep who received $2.4 million as one of the whistleblowers in the $2.3 billion Bextra settlement, alleged that reps used unapproved studies and pricing sheets to promote Viagra, among other drugs. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 08 Sep 2009 10:32:34 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pricing+strategy.html"><![CDATA[Pricing Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+rep.html"><![CDATA[Pfizer Rep]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Cialis Goes Up Against Viagra in Hypertension Add-On War]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003754/cialis-goes-up-against-viagra-in-hypertension-add-on-war/]]></link>
		<description><![CDATA[United Therapeutics has begun marketing a pulmonary arterial hypertension drug, Adcirca, made from Eli Lilly's Cialis ED drug, according to Investor's Business Daily. It will compete with Pfizer's Revatio, a PAH drug made from Viagra. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 18 Aug 2009 09:20:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/cialis.html"><![CDATA[Cialis]]></category>
		<category domain="http://resources.bnet.com/topic/united+therapeutics.html"><![CDATA[United Therapeutics]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Lilly Q2: It's Downhill From Here, Say Analysts; Cialis Gains on Viagra]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10003228/lilly-q2-its-downhill-from-here-say-analysts-cialis-gains-on-viagra/]]></link>
		<description><![CDATA[Eli Lillys' revenues from Effient prasugrel were conspicuous by their absence in the company's Q2 2009 earnings report today. Launched in several countries in Q2, prasugrel made only $300,000. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 22 Jul 2009 11:49:06 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/earnings+report.html"><![CDATA[Earnings Report]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lillys.html"><![CDATA[Eli Lillys]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pfizer's Foreign Viagra Ads: Mailman Jokes; Space Sperm and the Fountain of Youth]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002914/pfizers-foreign-viagra-ads-mailman-jokes-space-sperm-and-the-fountain-of-youth/]]></link>
		<description><![CDATA[Pfizer has been criticized before -- once by the FDA -- for advertising Viagra in a way that was too light-hearted for a drug intended to treat a medical condition. But that has not stopped the company commissioning a slew of entertaing ads in foreign countries. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 29 Jun 2009 20:14:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Congress Eyes Daytime Ban on Ads for Viagra et al]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10002012/congress-eyes-daytime-ban-on-ads-for-viagra-et-al/]]></link>
		<description><![CDATA[U.S. Rep. Jim Moran has introduced a bill that would ban ED ads on TV between 6 a.m. and 10 p.m, according to Ad Age. The ban would obviously affect Pfizer, Bayer and Eli Lilly ... by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 07 May 2009 08:59:55 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advertisement.html"><![CDATA[Advertisement]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pfizer Q1: Worse Than It Looks; Even Viagra Is Flagging]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001835/pfizer-q1-worse-than-it-looks-even-viagra-is-flagging/]]></link>
		<description><![CDATA[Pfizer's Q1 2009 numbers are worse than they appear at first glance. An accounting maneuver makes the company look much more productive than it is; and sales of its key franchises are weak -- even Viagra, down 1 percent, seems to have reached its peak. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 28 Apr 2009 07:36:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+q1+2009+number.html"><![CDATA[Pfizer Q1 2009 Number]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/financial+services.html"><![CDATA[Financial Services]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer Probes Release of Viagra Boxer Shorts to Irish Doctors]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001714/pfizer-probes-release-of-viagra-boxer-shorts-to-irish-doctors/]]></link>
		<description><![CDATA[Pfizer has launched an "internal investigation" into how a bunch of promotional Viagra boxer shorts ended up being sent to doctors in Ireland. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 16 Apr 2009 03:51:57 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Rexahn, Vivus Believe the World Needs 2 More ED Drugs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000973/rexahn-vivus-believe-the-world-needs-2-more-ed-drugs/]]></link>
		<description><![CDATA[Two companies are developing new erectile dysfunction drugs, even though there's already three on the market and one of those -- Pfizer's Viagra -- is set to go generic between 2011 and 2013.    Rexahn is developing a compound called Zoraxel and Vivus is developing Avanafil. Rexahn is...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 12 Feb 2009 03:00:25 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/rexahn.html"><![CDATA[Rexahn]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Swiss Allege Price Fixing on Viagra and Cialis]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000958/swiss-allege-price-fixing-on-viagra-and-cialis/]]></link>
		<description><![CDATA[Swiss authorities have accused Pfizer and Eli Lilly of conspiring to fix prices for Viagra and Cialis. The news has created the best Bloomberg headline ever: "Pfizer, Lilly, Bayer Operated Erection-Drug Cartel, Swiss Say."    A couple of days ago BNET noted that Pfizer and Lilly appear to...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 10 Feb 2009 16:40:19 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bayer+ag.html"><![CDATA[Bayer AG]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAYR Y</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">BAYR Y,PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer, Lilly Have Won the ED War; Bayer Wilts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000890/pfizer-lilly-have-won-the-ed-war-bayer-wilts/]]></link>
		<description><![CDATA[Pfizer and Eli Lilly appear to have definitively won the erectile dysfunction war: their respective brands, Viagra and Cialis, both showed sales growth in Q4 2008 and for the full year. Lilly's growth was slightly faster, but it is coming off a smaller base.    Bayer's brand, Levitra,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 06 Feb 2009 07:14:32 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/bayer+ag.html"><![CDATA[Bayer AG]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BAYR Y</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">BAYR Y,PFE</category>
	</item>
	<item>
		<title><![CDATA[List of 56 Drugs That Should Not Be Mixed With Viagra Contains Some Surprises]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000558/list-of-56-drugs-that-should-not-be-mixed-with-viagra-contains-some-surprises/]]></link>
		<description><![CDATA[Public Citizen has published a list of 56 drugs that interact badly with erectile dysfunction pills such as Pfizer's Viagra. Public Citizen's WorstPills.com site reports:  In combination with ED drugs, these 56 drugs can cause dangerous falls in blood pressure that could lead to a heart attack or stroke;...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 06 Jan 2009 07:22:58 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/blood+pressure.html"><![CDATA[Blood Pressure]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[How to Blunt Shareholder Activism: Ask It for a Date]]></title>
		<link><![CDATA[http://blogs.bnet.com/ceo/?p=1573]]></link>
		<description><![CDATA[Attention CEOs: here's a novel way of blunting unwanted criticism from shareholders.    For years, Evelyn Y. Davis, a self-styled 79-year-old corporate governance gadfly, has lambasted management at annual meetings of many marquee name firms. From her office at the Watergate of Richard Nixon fame, Davis pores over...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 17 Dec 2008 12:35:37 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/shareholder.html"><![CDATA[Shareholder]]></category>
		<category domain="http://resources.bnet.com/topic/annual+meeting.html"><![CDATA[Annual Meeting]]></category>
		<category domain="http://resources.bnet.com/topic/procter+%2526+gamble+co..html"><![CDATA[Procter & Gamble Co.]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/peter+galuszka.html"><![CDATA[Peter Galuszka]]></category>
		<category domain="http://resources.bnet.com/topic/peter+galuszka.html"><![CDATA[Peter Galuszka]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
		<category domain="tickers">PG</category>
	</item>
	<item>
		<title><![CDATA[Will P&G Pharma Auction End the Company's Pursuit of "Viagra for Women"?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000491/will-pg-pharma-auction-end-the-companys-pursuit-of-viagra-for-women/]]></link>
		<description><![CDATA[Procter & Gamble's desire to get out of the prescription pharmaceutical business either by selling its brands or managing them through their natural declines raises the question of whether this will finally kill P&G's longtime, ill-fated interest in creating a version of Viagra for women. BNET readers will remember that...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 11 Dec 2008 14:31:36 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[Brand]]></category>
		<category domain="http://resources.bnet.com/topic/women.html"><![CDATA[Women]]></category>
		<category domain="http://resources.bnet.com/topic/procter+%2526+gamble+co..html"><![CDATA[Procter & Gamble Co.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/auction.html"><![CDATA[Auction]]></category>
		<category domain="http://resources.bnet.com/topic/viagra.html"><![CDATA[Viagra]]></category>
		<category domain="http://resources.bnet.com/topic/noven.html"><![CDATA[Noven]]></category>
		<category domain="http://resources.bnet.com/topic/zestra.html"><![CDATA[Zestra]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/branding.html"><![CDATA[Branding]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
		<category domain="tickers">PG</category>
	</item>
</channel>
</rss>
